Why companies pay a premium for battle-tested CFOs—and Nike’s struggling turnaround shows the cost10 July 2026
TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling?By Press Room27 April 2026 In early April 2026, President Trump signed an executive order declaring that imported pharmaceutical products pose a threat to U.S.…
Direct-To-Consumer Pricing As A Model For Healthcare ReformBy Press Room8 September 2025 Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month—well below the $2,000 list…